Skip to main content

Advertisement

Table 1 Characteristics of subjects

From: Glucagon-like peptide 1 improved glycemic control in type 1 diabetes

  Dose Study 8-Hour Study 5-Day Study
N 15 9 8
Sex 9M/6F 4M/5F 5M/3F
Age, y 40 ± 4 36 ± 5 34 ± 3
BMI 24.6 ± 0.9 24.7 ± 0.9 25.4 ± 1.3
Duration of T1D, y 16 ± 3 18 ± 5 15 ± 4
Insulin dose, U/kg/d 0.66 ± 0.10 0.79 ± 0.15 0.73 ± 0.07
Fasting glucose, mmol/l 5.9 ± 0.5 5.5 ± 0.6 6.9 ± 0.6
A1c, % 6.5 ± 0.3 6.5 ± 0.3 6.5 ± 0.4